Literature DB >> 16498054

Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass.

Nicole Unger1, Christian Pitt, Ingo Lopez Schmidt, Martin K Walz, Kurt W Schmid, Thomas Philipp, Klaus Mann, Stephan Petersenn.   

Abstract

OBJECTIVE: Pheochromocytomas are neoplasms generally characterized by the autonomous production of catecholamines. This study compared various biochemical parameters for the diagnosis of adrenal pheochromocytoma in patients with adrenal mass.
DESIGN: One hundred and fifty subjects were studied, including 24 histologically proven pheochromocytomas, 17 aldosterone-secreting and 21 cortisol-secreting adrenal adenomas and 30 nonfunctioning adrenal masses, 16 patients with essential hypertension and 42 healthy normotensive volunteers. Spontaneous blood samples and 24-h urine samples were collected prospectively.
METHODS: Plasma and urinary epinephrine and norepinephrine levels were measured by high performance liquid chromatography, whereas plasma and urinary metanephrine and normetanephrine levels were determined by radioimmunoassay (RIA). Putative ratio thresholds were calculated by receiver operating characteristic (ROC) analysis to balance between sensitivity and specificity.
RESULTS: Plasma normetanephrine was found to be the best single parameter with the highest sensitivity (91.7%) and specificity (95.6%) using a threshold of 126 pg/ml. In combination, plasma normetanephrine and metanephrine had a higher sensitivity of 95.8% with lower specificity (79.4%). All other combinations of plasma and/or urinary parameters demonstrated a lower accuracy.
CONCLUSION: Plasma metanephrines measured by RIA are reliable screening parameters for the diagnosis of pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498054     DOI: 10.1530/eje.1.02097

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  24 in total

Review 1.  New roles of carboxypeptidase E in endocrine and neural function and cancer.

Authors:  Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh
Journal:  Endocr Rev       Date:  2012-03-07       Impact factor: 19.871

2.  A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis?

Authors:  Michelangelo Sartori; Alessandro Cosenzi; Elena Bernobich; Lorenzo A Calo; Giuseppe Bellini; Andrea Semplicini
Journal:  Intern Emerg Med       Date:  2008-02-09       Impact factor: 3.397

3.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

4.  Symptom-dependent cut-offs of urine metanephrines improve diagnostic accuracy for detecting pheochromocytomas in two separate cohorts, compared to symptom-independent cut-offs.

Authors:  Yoon Young Cho; Kee-Ho Song; Young Nam Kim; Seong Hee Ahn; Hyeonmok Kim; Sooyoun Park; Sunghwan Suh; Beom-Jun Kim; Soo-Youn Lee; Sail Chun; Jung-Min Koh; Seung Hun Lee; Jae Hyeon Kim
Journal:  Endocrine       Date:  2016-08-02       Impact factor: 3.633

Review 5.  Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.

Authors:  Graeme Eisenhofer; Arthur S Tischler; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

6.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 7.  The importance of standardisation of measurement and reference intervals for detection of phaeochromocytoma and paraganglioma (PPGL).

Authors:  Tomás P Griffin; Delia Bogdanet; Patrick Navin; Grace Callagy; Paula M O'Shea; Marcia Bell
Journal:  Ir J Med Sci       Date:  2018-02-19       Impact factor: 1.568

8.  Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma.

Authors:  Graeme Eisenhofer; Peter Lattke; Maria Herberg; Gabriele Siegert; Nan Qin; Roland Därr; Jana Hoyer; Arno Villringer; Aleksander Prejbisz; Andrzej Januszewicz; Alan Remaley; Victoria Martucci; Karel Pacak; H Alec Ross; Fred C G J Sweep; Jacques W M Lenders
Journal:  Ann Clin Biochem       Date:  2012-10-12       Impact factor: 2.057

Review 9.  Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas.

Authors:  G Eisenhofer; G Siegert; J Kotzerke; S R Bornstein; K Pacak
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

10.  Advances in biochemical screening for phaeochromocytoma using biogenic amines.

Authors:  Malcolm J Whiting; Matthew P Doogue
Journal:  Clin Biochem Rev       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.